Orchid Chemicals & Pharmaceuticals Ltd
  Home   Search   Online Newsletter   Sitemap  
line
line
line
Home > Corporate Info > Alliances / Joint Ventures
Alliances / Joint Ventures


China JV - NCPC-Orchid Pharmaceuticals Ltd.
Considering the potential of the Chinese market, Orchid entered into a manufacturing and marketing joint venture with the North China Pharmaceutical Corporation (NCPC), the largest pharmaceutical group in China.

China is reckoned as one of the most competitive manufacturing bases in the world and is also a fast growing market for pharmaceuticals and the single largest market for Orchid's cephalosporin products. Given Orchid's strengths in technology and manufacturing and NCPC's wide market presence in China, this venture (NCPC-Orchid) provides Orchid a strong presence in the Chinese market.

Alliances
Orchid’s quality manufacturing competence and international regulatory focus has resulted in exclusive marketing and distribution alliances with several global pharmaceutical corporations including Apotex, Actavis, Hospira and Dava among others. Each alliance is unique and covers key products, geographies and therapy segments across cephalosporin and non-cephalosporin products.
Terms of Use | Privacy Policy | Web Master | Safe Harbour | Site map

© 2006. Orchid Chemicals & Pharmaceuticals Ltd. All rights reserved.
Orchid Chemicals & Pharmaceuticals Ltd